Status:
RECRUITING
Non-small Cell Lung Cancer With Central Nervous System Metastasis
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Lung Cancer With Central Nervous System Metastasis
Eligibility:
All Genders
20-90 years
Brief Summary
Cerebrospinal fluid was obtained from the cerebrospinal cavity of non-small cell lung cancer patients with central nervous system metastasis, blood was obtained from veins, and metastatic lung cancer ...
Eligibility Criteria
Inclusion
- \- A. Non-small cell lung cancer patients diagnosed with brain metastases or meningeal metastases on brain computed tomography (CT) or magnetic resonance (MRI) images.
- B. Patients with non-small cell lung cancer who are about to undergo surgical brain surgery, such as brain tumor resection, lumbar abdominal drainage, Euclidean storage, or ventriculoperitoneal drainage.
Exclusion
- \- A. Non-small cell lung cancer patients without brain metastases or meningeal metastases.
- B. Physical condition does not allow surgical removal of the tumor.
Key Trial Info
Start Date :
January 13 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06026735
Start Date
January 13 2023
End Date
December 1 2027
Last Update
September 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100